|
|
E8ER1912-23
|
EnoGene |
|
100ul |
|
|
|
|
|
|
|
T32614-10mg
|
TargetMol Chemicals |
|
10mg |
|
|
|
T32614-1g
|
TargetMol Chemicals |
|
1g |
|
|
|
T32614-1mg
|
TargetMol Chemicals |
|
1mg |
|
|
|
T32614-50mg
|
TargetMol Chemicals |
|
50mg |
|
|
|
T32614-5mg
|
TargetMol Chemicals |
|
5mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ABC-SC2088
|
AcceGen |
|
1 vial |
|
|
|
MC212743
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MC212744
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MC212745
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG214304
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG220664
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
SC107411
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
SC300422
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MG226111
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MG226117
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MG226119
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
ABC-KH8338
|
AcceGen |
|
1 vial |
|
|
|
MR226111
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226117
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226119
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC214304
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC220664
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
ABC-KD8338
|
AcceGen |
|
1 vial |
|
|
|
IHULCLAT1PLLY20UG
|
Innovative research |
|
each |
|
|
|
MR226111L3
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226111L4
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226117L3
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226117L4
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226119L3
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MR226119L4
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC214304L4
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|